Cargando…

Combination Therapy for HIV-Associated Cryptococcal Meningitis—A Success Story

Cryptococcal meningitis is the leading cause of adult meningitis in patients with HIV, and accounts for 15% of all HIV-related deaths in sub-Saharan Africa. The mainstay of management is effective antifungal therapy, despite a limited arsenal of antifungal drugs, significant progress has been made d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurt, William J., Harrison, Thomas S., Molloy, Síle F., Bicanic, Tihana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708058/ https://www.ncbi.nlm.nih.gov/pubmed/34947080 http://dx.doi.org/10.3390/jof7121098

Ejemplares similares

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis
por: Stone, Neil R.H., et al.
Publicado: (2019)

Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis
por: Eshun‐Wilson, Ingrid, et al.
Publicado: (2018)

Cryptococcal meningitis: A neglected NTD?
por: Molloy, Síle F., et al.
Publicado: (2017)

Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
por: Bicanic, Tihana, et al.
Publicado: (2015)

Cerebrospinal Fluid Cytokine Profiles Predict Risk of Early Mortality and Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis
por: Jarvis, Joseph N., et al.
Publicado: (2015)

Very Low Levels of 25-Hydroxyvitamin D Are Not Associated With Immunologic Changes or Clinical Outcome in South African Patients With HIV-Associated Cryptococcal Meningitis
por: Jarvis, Joseph N., et al.
Publicado: (2014)

Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes
por: Jarvis, Joseph N., et al.
Publicado: (2014)

One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi
por: Kanyama, Cecilia, et al.
Publicado: (2020)

Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis
por: Molloy, Síle F, et al.
Publicado: (2021)

Immune correlates of HIV-associated cryptococcal meningitis
por: Tenforde, Mark W., et al.
Publicado: (2017)

Cryptococcus neoformans Ex Vivo Capsule Size Is Associated With Intracranial Pressure and Host Immune Response in HIV-associated Cryptococcal Meningitis
por: Robertson, Emma J., et al.
Publicado: (2014)

Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa
por: Beale, Mathew A., et al.
Publicado: (2015)

Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis
por: Molloy, Síle F., et al.
Publicado: (2018)

Recent advances in managing HIV-associated cryptococcal meningitis
por: Boyer-Chammard, Timothée, et al.
Publicado: (2019)

The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort()
por: Patel, Sheel, et al.
Publicado: (2013)

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa
por: Kalata, Newton, et al.
Publicado: (2021)

Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance
por: Hope, William, et al.
Publicado: (2019)

Treatment for HIV‐associated cryptococcal meningitis
por: Tenforde, Mark W, et al.
Publicado: (2018)

A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection
por: Rhodes, Johanna, et al.
Publicado: (2017)

High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis
por: Zhao, Hua-Zhen, et al.
Publicado: (2018)

Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa
por: Jarvis, Joseph N., et al.
Publicado: (2013)

Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV
por: O’Kelly, Brendan, et al.
Publicado: (2021)

P449 Semi-quantitative cryptococcal antigen rapid test (CryptoPS, Biosynex®) for cryptococcal meningitis in patients living with HIV in Sub-Saharan Africa: prospective multicenter diagnostic accuracy study (DREAMM)
por: Leclere, Research Engineer Aude Sturny, et al.
Publicado: (2022)

1593 Predictors of Mortality for HIV-associated Cryptococcal Meningitis
por: Nimitvilai, Sireethorn, et al.
Publicado: (2014)

Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa
por: Chen, Tao, et al.
Publicado: (2019)

Noninvasive intracranial pressure monitoring for HIV-associated cryptococcal meningitis
por: Bollela, V.R., et al.
Publicado: (2017)

Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications
por: Wake, Rachel M, et al.
Publicado: (2022)

Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis
por: Liu, Jia, et al.
Publicado: (2018)

Cryptococcal Meningitis in a HIV-Negative Patient
por: Barreiros, Cátia, et al.
Publicado: (2018)

Cryptococcal Meningitis in an HIV-Negative Puerperal Woman
por: Robalo Nunes, Tomás, et al.
Publicado: (2021)

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
por: Jarvis, Joseph N, et al.
Publicado: (2022)

Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis
por: Shiri, Tinevimbo, et al.
Publicado: (2020)

Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2022)

Thalidomide for Recurrence of Symptoms following HIV-Associated Cryptococcal Meningitis
por: Qi, Tangkai, et al.
Publicado: (2023)

Genomic epidemiology of Cryptococcus yeasts identifies adaptation to environmental niches underpinning infection across an African HIV/AIDS cohort
por: Vanhove, Mathieu, et al.
Publicado: (2016)

Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis
por: Concha-Velasco, Fátima, et al.
Publicado: (2017)

Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death
por: Rutakingirwa, Morris K., et al.
Publicado: (2020)

Risk factors in HIV/AIDS patients with cryptococcal meningitis
por: Bădicuț, Ioana, et al.
Publicado: (2014)

Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis
por: Panackal, Anil A., et al.
Publicado: (2015)

Combination Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Whom, When, and Where?
por: Siedner, Mark J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ehe668na5pp4nmthrqh7moi27j